Search for: "OSI, Inc."
Results 61 - 68
of 68
Sorted by Relevance
|
Sort by Date
23 Jun 2007, 4:00 pm
Tiemann argues that the term should only be used to refer to licenses and software that adhere to the OSI's definition of open source. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog) (Managing… [read post]
3 May 2023, 9:00 pm
; Randy Huffman, Ph.D, Chief Food Safety and Sustainability Officer, Maple Leaf Foods; and David McDonald, President and Chief Operating Officer, OSI Group will join Lone Jespersen, Ph.D., Principal, Cultivate SA, who will lead this important conversation. [read post]
24 Jan 2022, 9:05 pm
The USDA’s Food Safety and Inspection Service named its key achievements for 2021 that the agency claims highlight progress in its mission to prevent foodborne illness and protect public health. [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and de-branding of… [read post]
29 Aug 2008, 1:25 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
6 Aug 2015, 6:21 pm
John Reed Stark David Fontaine It is well understood by now that cyber security is a concern for every organization and that it is an issue on which every company’s board should be focused. [read post]
